Devin Smith

Devin Smith is the CEO of Arbor Biotechnologies, a company specializing in the development of advanced gene editing technologies and therapies. Under his leadership, Arbor is at the forefront of leveraging genomic science to create innovative treatments for rare and genetic diseases. Smith is recognized for his commitment to transforming genomic insights into practical therapies, and he actively collaborates with organizations like the Department of Health - Abu Dhabi to enhance clinical research and development in gene editing.